Vital Organs Support Systems and Medical Bionics Market by Product (Vital organs support systems and Medical Bionics) and End User (Hospitals, Ambulatory Surgical Centers, and Others): Global Opportunity Analysis and Industry Forecast, 20182025
- Published Date: 2020-10-18
- Report ID: 3541
- Pages: 293
-
Format:
The global vital organs support systems and medical bionics market size in 2017 is $28,169 million, and is projected to reach $59,412 million by 2025, growing at a CAGR of 10.9% from 2018 to 2025.
An artificial organ is an engineered device or tissue that is implanted or integrated into a human, interfacing with living tissue. Medical bionics, also known as biomedical implants, are artificial addition to the body. These artificial implants mimic the function of the lost or nonfunctional body part.
The vital organs support systems and medical bionics market is expected to exhibit significant growth during the forecast period due to rise in geriatric population, scarcity of donor organs, technological advancements in the artificial organ sector, and increase in R&D expenditure. In addition, rise in number of patients suffering from chronic diseases drives the market growth. However, high cost of artificial organs and stringent approval process are projected to impede growth of the vital organs support systems and medical bionics market. On the contrary, application of advanced biomaterials in artificial organs and lucrative opportunities in emerging economies are expected to provide significant prospects for the manufacturers in the industry.
The global vital organs support systems and medical bionics market is segmented based on product, end user, and region. Depending on product, the market is categorized into vital organs support systems and medical bionics. The vital organs support systems segment is further divided into artificial heart, artificial kidney, artificial pancreas, artificial urinary bladder, artificial lungs, and artificial liver. The medical bionics segment is subsegmented into bionic eye, ear bionics, orthopedic bionics, cardiac bionics, and neural bionics. Depending on end user, the market is segregated into hospitals, ambulatory surgical centers, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global vital organs support systems and medical bionics market is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
By Product
o Vital organs support systems
Artificial Heart
Artificial Kidney
Artificial Pancreas
Artificial Urinary Bladder
Artificial Lungs
Artificial Liver
o Medical Bionics
o Bionic Eye
o Ear Bionics
Cochlear Implants
Bone Anchored Hearing Systems
Auditory Brainstem Implants
o Orthopedic Bionics
Upper limb
Lower limb
Bionic Knee
Bionic Feet
Exoskeleton
Electrical Bone Growth Stimulators
Non-Invasive Bone Growth Stimulators
Invasive Bone Growth Stimulators
o Cardiac Bionics
Pacemaker
Implantable Pacemaker
External Pacemaker
Ventricular Assist Device
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Artificial Heart Valves
Mechanical Heart Valves
Tissue Heart Valves
o Neural Bionics
Internal Neurostimulators
Deep Brain Stimulators (DBS)
Sacral Nerve Stimulators (SNS)
Vagus Nerve Stimulators (VNS)
Spinal Cord Stimulators (SCS)
Other Neurostimulators
External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
By End User
o Hospitals
o Ambulatory Surgical Centers
o Others
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
Abiomed, Inc.
Abbott Laboratories
Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
Baxter International Inc.
Boston Scientific Corporation
Cochlear Ltd.
Edwards Lifesciences Corporation
Jarvik Heart, Inc.
Medtronic Plc.
ssur Americas, Inc.
Second Sight Medical Products, Inc.
SynCardia Systems LLC
The other players in the value chain include (profiles not included in the report):
Getinge AB
LivaNova PLC
Fresenius Medical Care AG & Co. KGaA
Heartware International Inc.
BiVACOR
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping vital organs support systems and medical bionics Market
3.2.1. Moderate bargaining power of suppliers
3.2.2. Low threat of new entrants
3.2.3. Low threat of substitutes
3.2.4. Moderate intensity of rivalry
3.2.5. High bargaining power of buyers
3.3. Pricing Analysis
3.3.1. Pricing Analysis, By Region, 2018 & 2025
3.4. Value Chain Analysis
3.5. Impact of government regulations on global vital organs support systems and medical bionics market
3.6. Clinical Trials
3.7. Industry Pain point analysis
3.8. Case Studies
3.8.1. Case Study 01
3.9. Market dynamics
3.9.1. Drivers
3.9.1.1. Increase in incidence of cardiac disorders and growth in geriatric population
3.9.1.2. Rise in number of patients suffering from chronic diseases
3.9.1.3. Technological advancements
3.9.2. Restraints
3.9.2.1. High cost of treatment
3.9.2.2. Stringent approval process
3.9.3. Opportunities
3.9.3.1. Lucrative opportunities in emerging economies
CHAPTER 4: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.2. Market size and forecast
4.3. Vital organs support systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Artificial Heart
4.3.2.1.1. Market size and forecast
4.3.2.2. Artificial Kidney
4.3.2.2.1. Market size and forecast
4.3.2.3. Artificial Pancreas
4.3.2.3.1. Market size and forecast
4.3.2.4. Artificial Urinary Bladder
4.3.2.4.1. Market size and forecast
4.3.2.5. Artificial Lungs
4.3.2.5.1. Market size and forecast
4.3.2.6. Artificial Liver
4.3.2.6.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis by country
4.4. Medical Bionics
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Bionic Eye
4.4.2.1.1. Market size and forecast
4.4.2.2. Ear Bionics
4.4.2.2.1. Market size and forecast, by type
4.4.2.2.1.1.1. Cochlear Implants
4.4.2.2.1.1.1.1 Market size and forecast
4.4.2.2.1.1.2. Bone Anchored Hearing Systems
4.4.2.2.1.1.2.1. Market size and forecast
4.4.2.2.1.1.3. Auditory Brainstem Implants
4.4.2.2.1.1.3.1 Market size and forecast
4.4.2.3. Orthopedic Bionics
4.4.2.3.1. Market size and forecast, by type
4.4.2.3.1.1.1. Upper Limb
4.4.2.3.1.1.2. Market size and forecast
4.4.2.3.1.1.3. Lower Limb
4.4.2.3.1.1.4. Market size and forecast, by type
4.4.2.3.1.1.4.1. Bionic Knee
4.4.2.3.1.1.4.1.1. Market size and forecast
4.4.2.3.1.1.4.2. Bionic Feet
4.4.2.3.1.1.4.2.1. Market size and forecast
4.4.2.3.1.1.5. Exoskeleton
4.4.2.3.1.1.6. Market size and forecast
4.4.2.3.1.1.7. Electrical Bone Growth Stimulators
4.4.2.3.1.1.8. Market size and forecast, by type
4.4.2.3.1.1.8.1. Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.1.1. Market size and forecast
4.4.2.3.1.1.8.2. Non-Invasive Bone Growth Stimulators
4.4.2.3.1.1.8.2.1. Market size and forecast
4.4.2.4. Cardiac Bionics
4.4.2.4.1. Market size and forecast, by type
4.4.2.4.1.1.1. Pacemaker
4.4.2.4.1.1.1.1 Market size and forecast, by type
4.4.2.4.1.1.2. Implantable Pacemaker
4.4.2.4.1.1.2.1. Market size and forecast
4.4.2.4.1.1.3. External pacemaker
4.4.2.4.1.1.3.1 Market size and forecast
4.4.2.4.1.1.3. Ventricular Assist Devices (VADs)
4.4.2.4.1.1.4. Market size and forecast, by type
4.4.2.4.1.1.4.1. Left Ventricular Assist Device (LVAD)
4.4.2.4.1.1.4.1.1. Market size and forecast
4.4.2.4.1.1.4.2. Right Ventricular Assist Device (RVAD)
4.4.2.4.1.1.4.2.1. Market size and forecast
4.4.2.4.1.1.4.3. Biventricular Assist Device (BIVAD)
4.4.2.4.1.1.4.3.1. Market size and forecast
4.4.2.4.1.1.5. Artificial Heart Valves
4.4.2.4.1.1.6. Market size and forecast, by type
4.4.2.4.1.1.6.1. Mechanical Heart Valves
4.4.2.4.1.1.6.1.1. Market size and forecast
4.4.2.4.1.1.6.2. Tissue Heart Valves
4.4.2.4.1.1.6.2.1. Market size and forecast
4.4.2.5. Neural Bionics
4.4.2.5.1. Market size and forecast, by type
4.4.2.5.1.1. Internal Neurostimulators
4.4.2.5.1.1.1. Market size and forecast, by type
4.4.2.5.1.1.1.1. Deep Brain Stimulators (DBS)
4.4.2.5.1.1.1.1.1. Market size and forecast
4.4.2.5.1.1.1.2. Sacral Nerve Stimulators (SNS)
4.4.2.5.1.1.1.2.1. Market size and forecast
4.4.2.5.1.1.1.3. Vagus Nerve Stimulators (VNS)
4.4.2.5.1.1.1.3.1. Market size and forecast
4.4.2.5.1.1.1.4. Spinal Cord Stimulators (SCS)
4.4.2.5.1.1.1.4.1. Market size and forecast
4.4.2.5.1.1.1.5. Other Neurostimulators
4.4.2.5.1.1.1.5.1. Market size and forecast
4.4.2.5.1.2. External Neurostimulators (Transcutaneous Electrical Nerve Stimulation (TENS))
4.4.2.5.1.2.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis by country
CHAPTER 5: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY END USER
5.1. Overview
5.2. Market size and forecast
5.3. Hospitals
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Ambulatory surgical centers (ASCs)
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: VITAL ORGANS SUPPORT SYSTEMS AND MEDICAL BIONICS MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America vital organs support systems and medical bionics market, by country
6.2.2.1. U.S. vital organs support systems and medical bionics market, by product type
6.2.2.2. U.S. vital organs support systems and medical bionics market, by end user
6.2.2.3. Canada vital organs support systems and medical bionics market, by product type
6.2.2.4. Canada vital organs support systems and medical bionics market, by end user
6.2.2.5. Mexico vital organs support systems and medical bionics market, by product type
6.2.2.6. Mexico vital organs support systems and medical bionics market, by end user
6.2.3. North America vital organs support systems and medical bionics market, by product type
6.2.5. North America vital organs support systems and medical bionics market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe vital organs support systems and medical bionics market, by country
6.3.2.1. Germany vital organs support systems and medical bionics market, by product type
6.3.2.3. Germany vital organs support systems and medical bionics market, by end user
6.3.2.4. France vital organs support systems and medical bionics market, by product type
6.3.2.6. France vital organs support systems and medical bionics market, by end user
6.3.2.7. Spain vital organs support systems and medical bionics market, by product type
6.3.2.8. Spain vital organs support systems and medical bionics market, by end user
6.3.2.9. Italy vital organs support systems and medical bionics market, by product type
6.3.2.11. Italy vital organs support systems and medical bionics market, by end user
6.3.2.12. UK vital organs support systems and medical bionics market, by product type
6.3.2.13. UK vital organs support systems and medical bionics market, by end user
6.3.2.14. Rest of Europe vital organs support systems and medical bionics market, by product type
6.3.2.15. Rest of Europe vital organs support systems and medical bionics market, by end user
6.3.3. Europe vital organs support systems and medical bionics market, by product type
6.3.5. Europe vital organs support systems and medical bionics market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific vital organs support systems and medical bionics market, by country
6.4.2.1. Australia vital organs support systems and medical bionics market, by product type
6.4.2.2. Australia vital organs support systems and medical bionics market, by end user
6.4.2.3. Japan vital organs support systems and medical bionics market, by product type
6.4.2.4. Japan vital organs support systems and medical bionics market, by end user
6.4.2.5. India vital organs support systems and medical bionics market, by product type
6.4.2.6. India vital organs support systems and medical bionics market, by end user
6.4.2.7. China vital organs support systems and medical bionics market, by product type
6.4.2.8. China vital organs support systems and medical bionics market, by end user
6.4.2.9. South Korea vital organs support systems and medical bionics market, by product type
6.4.2.10. South Korea vital organs support systems and medical bionics market, by end user
6.4.2.11. Rest of Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.2.12. Rest of Asia-Pacific vital organs support systems and medical bionics market, by end user
6.4.3. Asia-Pacific vital organs support systems and medical bionics market, by product type
6.4.5. Asia-Pacific vital organs support systems and medical bionics market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA vital organs support systems and medical bionics market, by country
6.5.2.1. Brazil vital organs support systems and medical bionics market, by product type
6.5.2.2. Brazil vital organs support systems and medical bionics market, by end user
6.5.2.3. Saudi Arabia vital organs support systems and medical bionics market, by product type
6.5.2.4. Saudi Arabia vital organs support systems and medical bionics market, by end user
6.5.2.5. South Africa vital organs support systems and medical bionics market, by product type
6.5.2.6. South Africa vital organs support systems and medical bionics market, by end user
6.5.2.7. Rest of LAMEA vital organs support systems and medical bionics market, by product type
6.5.2.8. Rest of LAMEA vital organs support systems and medical bionics market, by end user
6.5.3. LAMEA vital organs support systems and medical bionics market, by product type
6.5.5. LAMEA vital organs support systems and medical bionics market, by end user
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.4. Top winning strategies
7.4.1. Top Winning Strategies, By Year, 2015-2019*
7.4.2. Top Winning Strategies, By Development, 2015-2019* (%)
7.4.3. Top Winning Strategies, By Company, 2015-2019*
7.5. Product Mapping of Top 12 Player
CHAPTER 8: COMPANY PROFILES:
8.1. Abiomed, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Product portfolio
8.1.4. Business performance
8.1.5. Key strategic moves and developments
8.2. Abbott Laboratories (St. Jude Medical)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. Baxter International Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. Boston Scientific Corporation
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Cochlear Ltd.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Edwards Lifesciences Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Jarvik Heart, Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Key strategic moves and developments
8.9. Medtronic Plc. (Covidien Ltd.)
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. ssur Americas, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
8.11. Second Sight Medical Products, Inc.
8.11.1. Company overview
8.11.2. Company snapshot
8.11.3. Product portfolio
8.11.4. Key strategic moves and developments
8.12. SynCardia Systems LLC
8.12.1. Company overview
8.12.2. Company snapshot
8.12.3. Product portfolio
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
